Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
World Journal of Gastroenterology|August 22, 2007
Hepatocellular carcinoma with chronic B-type hepatitis complicated by autoimmune hemolytic anemia: a case reportToshie Okada, Keiichi Kubota, Junji Kita, et al.
Hepato-Gastroenterology|November 21, 2007
A novel anti-cancer substance, MK615, from ume, a variety of Japanese apricot, inhibits growth of hepatocellular carcinoma cells by suppressing Aurora A kinase activityToshie Okada, Tokihiko Sawada, Tatsushi Osawa, et al.
Hepato-Gastroenterology|April 11, 2014
Results of pancreaticoduodenectomy with portal or superior mesenteric vein resection for locally advanced pancreatic head cancerMitsugi Shimoda, Shozo Mori, Junji Kita, et al.
Clinical Transplantation|May 15, 2004
Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantationTokihiko Sawada, Shohei Fuchinoue, Tomonori Kawase, et al.
Clinical Transplantation|January 22, 2005
Lobular damage caused by cellular and humoral immunity in liver allograft rejectionTokihiko Sawada, Akira Shimizu, Keiichi Kubota, et al.
Hepato-Gastroenterology|February 13, 2008
Hepatectomy for metastatic liver tumor in patients with liver dysfunctionTokihiko Sawada, Junji Kita, Hitoshi Nagata, et al.
Chemotherapy|November 25, 2010
The Glasgow Prognostic Score is a good predictor of treatment outcome in patients with unresectable pancreatic cancerMitsugi Shimoda, Masato Katoh, Junji Kita, et al.
Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|December 17, 2009
Valve system does not reduce the catheter-related bloodstream infectionMitsuru Ishizuka, Hitoshi Nagata, Kazutoshi Takagi, et al.
American Journal of Surgery|April 23, 2010
An alternative tool for intraoperative assessment of renal vasculature after revascularization of a transplanted kidneyTokihiko Sawada, Mizrahi Solly, Junji Kita, et al.
Cancer Cell International|October 24, 2002
Xenoantigen, an alphaGal epitope-expression construct driven by the hTERT-promoter, specifically kills human pancreatic cancer cell lineTokihiko Sawada, Osamu Yamada, Naoko Yoshimura, et al.
Pageof 9